Your browser is no longer supported. Please, upgrade your browser.
Settings
CORI Corium International, Inc. daily Stock Chart
CORI [NASD]
Corium International, Inc.
Index- P/E- EPS (ttm)-1.72 Insider Own0.60% Shs Outstand37.39M Perf Week-4.11%
Market Cap383.62M Forward P/E- EPS next Y-1.34 Insider Trans- Shs Float35.48M Perf Month3.53%
Income-44.20M PEG- EPS next Q-0.40 Inst Own91.00% Short Float5.41% Perf Quarter12.50%
Sales30.30M P/S12.66 EPS this Y-8.30% Inst Trans0.01% Short Ratio12.11 Perf Half Y125.49%
Book/sh0.87 P/B11.79 EPS next Y21.20% ROA-61.20% Target Price13.00 Perf Year95.80%
Cash/sh1.78 P/C5.76 EPS next 5Y- ROE-673.10% 52W Range2.67 - 11.37 Perf YTD152.71%
Dividend- P/FCF- EPS past 5Y- ROI-53.60% 52W High-9.76% Beta1.22
Dividend %- Quick Ratio6.80 Sales past 5Y- Gross Margin17.40% 52W Low284.10% ATR0.52
Employees212 Current Ratio7.00 Sales Q/Q-23.60% Oper. Margin- RSI (14)51.77 Volatility6.39% 5.01%
OptionableNo Debt/Eq1.89 EPS Q/Q-26.80% Profit Margin- Rel Volume0.81 Prev Close9.79
ShortableYes LT Debt/Eq1.89 EarningsNov 02 AMC Payout- Avg Volume158.47K Price10.26
Recom1.80 SMA20-4.26% SMA5010.26% SMA20060.98% Volume128,207 Change4.80%
Sep-26-17Initiated H.C. Wainwright Buy $15
Aug-07-17Reiterated Jefferies Buy $8 → $10
Apr-18-17Reiterated FBR & Co. Outperform $12 → $13
Feb-14-17Reiterated Needham Buy $12 → $10
May-03-16Upgrade WBB Securities Hold → Speculative Buy $11
Feb-09-16Reiterated Needham Buy $16 → $15
Nov-16-15Reiterated Needham Buy $18 → $16
Aug-31-15Downgrade WBB Securities Buy → Hold $5.75 → $11
Jun-18-15Reiterated Needham Buy $12 → $18
Jun-09-15Initiated Guggenheim Buy
Jun-05-15Reiterated FBR Capital Outperform $12 → $16
May-08-15Reiterated Leerink Partners Outperform $10 → $13
May-08-15Reiterated FBR Capital Outperform $10 → $12
Apr-02-15Resumed FBR Capital Outperform $10
Apr-28-14Initiated Needham Buy $12
Apr-28-14Initiated FBR Capital Outperform $11
Oct-16-17 09:50AM  ETFs with exposure to Corium International, Inc. : October 16, 2017 Capital Cube
Sep-29-17 09:02AM  Corium International, Inc. :CORI-US: Earnings Analysis: Q3, 2017 By the Numbers : September 29, 2017 Capital Cube
Sep-05-17 08:00AM  Corium to Present at Upcoming Healthcare Conferences GlobeNewswire
Aug-24-17 09:00AM  Aequus Announces Abbreviated Development Path for Transdermal Aripiprazole Marketwired +7.72%
Aug-12-17 08:01AM  Edited Transcript of CORI earnings conference call or presentation 3-Aug-17 9:00pm GMT Thomson Reuters StreetEvents
Aug-04-17 02:36AM  Corium reports 3Q loss Associated Press
Aug-03-17 04:02PM  Corium Reports Recent Corporate Highlights and Financial Results for Third Quarter Fiscal 2017 GlobeNewswire
01:40PM  Investor Network: Corium International, Inc. to Host Earnings Call ACCESSWIRE
Jul-27-17 04:05PM  Corium to Report Third Quarter Fiscal 2017 Financial Results on Thursday, August 3, 2017 GlobeNewswire
Jul-18-17 07:30AM  Corium Presents Clinical Results from Pilot Bioequivalence Study of Corplex Donepezil Transdermal System at Alzheimer's Association International Conference® 2017 GlobeNewswire
Jul-07-17 08:15AM  Corium International (CORI) Catches Eye: Stock Jumps 11.9% Zacks
Jul-06-17 08:30AM  Corium to Present Clinical Results from Pilot Bioequivalence Study of Once-weekly Corplex Donepezil Transdermal System at Alzheimer's Association International Conference® 2017 GlobeNewswire +11.95%
Jun-26-17 08:30AM  Corium Joins Russell 3000® Index GlobeNewswire
Jun-01-17 08:30AM  Corium to Present at the Jefferies 2017 Global Healthcare Conference GlobeNewswire
May-31-17 04:02PM  Corium Announces Closing of Follow-On Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares GlobeNewswire
May-25-17 12:37PM  ETFs with exposure to Corium International, Inc. : May 25, 2017 Capital Cube
08:30AM  Corium Prices Follow-On Offering of Common Stock GlobeNewswire
May-24-17 04:03PM  Corium Announces Proposed Public Offering of Common Stock GlobeNewswire +7.51%
09:34AM  Corium International, Inc. :CORI-US: Earnings Analysis: Q2, 2017 By the Numbers : May 24, 2017 Capital Cube
May-22-17 08:20AM  AxoGen (AXGN) Shows Strength: Stock Adds 6.1% in Session Zacks
May-18-17 01:16PM  Edited Transcript of CORI earnings conference call or presentation 11-May-17 12:30pm GMT Thomson Reuters StreetEvents +9.00%
05:23AM  Can The Uptrend Continue for Corium International (CORI)? Zacks
May-12-17 11:44AM  Edited Transcript of CORI earnings conference call or presentation 11-May-17 12:30pm GMT Thomson Reuters StreetEvents
May-11-17 09:16AM  Corium reports 2Q loss Associated Press +16.07%
07:02AM  Corium Reports Positive Preliminary Results in Alzheimers Clinical Study GlobeNewswire
07:00AM  Corium Reports Second Quarter Fiscal 2017 Financial Results and Recent Corporate Highlights GlobeNewswire
May-09-17 08:30AM  Corium to Report Preliminary Results from Corplex Donepezil Pilot Study and Second Quarter Fiscal 2017 Financial Results Before Market Open on Thursday, May 11, 2017 GlobeNewswire +5.69%
May-03-17 11:17AM  Shire (SHPG) Beats on Q1 Earnings & Sales, Reiterates View Zacks
Apr-24-17 10:28AM  Anthem (ANTM) to Report Q1 Earnings: A Beat in the Cards? Zacks
Apr-07-17 04:13PM  ETFs with exposure to Corium International, Inc. : April 7, 2017 Capital Cube
Mar-27-17 08:30AM  Corium to Present at the 16th Annual Needham Healthcare Conference GlobeNewswire
Mar-22-17 08:30AM  Corium to Participate in BioPharma Dealmakers Webcast on New Innovations in Drug Delivery Technology GlobeNewswire
Mar-20-17 08:30AM  Corium International, Inc. :CORI-US: Earnings Analysis: Q1, 2017 By the Numbers : March 20, 2017 Capital Cube
08:30AM  Corium International, Inc. :CORI-US: Earnings Analysis: Q1, 2017 By the Numbers : March 20, 2017
08:30AM  Corium Reports Positive Progress in Pilot Bioequivalence Study of Once-Weekly Corplex Donepezil Patch GlobeNewswire
Mar-09-17 04:31PM  CORIUM INTERNATIONAL, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Feb-17-17 01:04PM  CORIUM INTERNATIONAL, INC. Financials +9.40%
Feb-14-17 10:18AM  Edited Transcript of CORI earnings conference call or presentation 13-Feb-17 10:00pm GMT Thomson Reuters StreetEvents
06:18AM  CORIUM INTERNATIONAL, INC. Files SEC form 10-Q, Quarterly Report
Feb-13-17 05:30PM  Corium reports 1Q loss Associated Press
04:26PM  CORIUM INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an
04:02PM  Corium Reports First Quarter Fiscal 2017 Financial Results GlobeNewswire
07:07AM  Q1 2017 Corium International Inc Earnings Release - After Market Close
Feb-07-17 04:05PM  Corium to Present at Upcoming Investor Conferences GlobeNewswire
Feb-06-17 04:05PM  Corium to Report First Quarter Fiscal Year 2017 Financial Results on Monday, February 13, 2017 GlobeNewswire
Feb-02-17 04:44PM  CORIUM INTERNATIONAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial St -21.14%
08:30AM  Corium Prices Follow-On Offering of Common Stock GlobeNewswire
Feb-01-17 04:23PM  Corium Announces Proposed Public Offering of Common Stock GlobeNewswire
Jan-20-17 04:06PM  CORIUM INTERNATIONAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and E
Jan-09-17 07:02AM  CORIUM INTERNATIONAL, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -5.67%
Jan-06-17 11:35AM  ETFs with exposure to Corium International, Inc. : January 6, 2017
Dec-23-16 12:34PM  ETFs with exposure to Corium International, Inc. : December 23, 2016 +5.01%
08:24AM  Corium International, Inc. :CORI-US: Earnings Analysis: 2016 By the Numbers : December 23, 2016
Dec-20-16 04:04PM  CORIUM INTERNATIONAL, INC. Files SEC form 10-K, Annual Report
Dec-12-16 05:31PM  Is Xerium Technologies, Inc. (XRM) A Good Stock To Buy? at Insider Monkey
Dec-09-16 12:10PM  ETFs with exposure to Corium International, Inc. : December 9, 2016
Nov-28-16 10:57AM  Corium International, Inc. :CORI-US: Earnings Analysis: Q4, 2016 By the Numbers : November 28, 2016
Nov-21-16 10:47PM  Edited Transcript of CORI earnings conference call or presentation 21-Nov-16 10:00pm GMT -5.49%
04:46PM  Corium reports 4Q loss
04:13PM  CORIUM INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an
04:02PM  Corium Reports Fourth Quarter and Fiscal Year 2016 Financial Results and Recent Corporate Highlights GlobeNewswire
07:07AM  Q4 2016 Corium International Inc Earnings Release - After Market Close
Nov-17-16 09:00AM  Aequus Prepares for Proof of Concept Clinical Study for Transdermal Anti-Nausea Diclegis Program Marketwired
Nov-15-16 08:00AM  Corium to Report Fourth Quarter and Year-end Fiscal Year 2016 Financial Results on Monday, November 21, 2016 GlobeNewswire
Oct-13-16 08:00AM  Corium to Present at Dawson James Securities Growth Stock Conference GlobeNewswire
Aug-26-16 08:15AM  Corium International (CORI) Jumps: Stock Moves Up 6.9% -9.64%
Aug-24-16 08:00AM  Corium Announces Streamlined Bioequivalence Development Path for Transdermal Corplex Memantine GlobeNewswire +21.17%
Aug-23-16 11:37AM  ETFs with exposure to Corium International, Inc. : August 23, 2016
09:00AM  Movers and Shakers In Biotech: Cyclacel Pharmaceuticals Inc (CYCC) and Corium International Inc (CORI) at Insider Monkey
Aug-19-16 11:36AM  Edited Transcript of CORI earnings conference call or presentation 4-Aug-16 9:00pm GMT +11.71%
Aug-12-16 04:09PM  CORIUM INTERNATIONAL, INC. Files SEC form 10-Q, Quarterly Report
Aug-11-16 10:37AM  Corium International, Inc. :CORI-US: Earnings Analysis: Q3, 2016 By the Numbers : August 11, 2016 -6.36%
Aug-04-16 06:09PM  Corium reports 3Q loss
04:18PM  CORIUM INTERNATIONAL, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement, Results of Operations
04:01PM  Corium Reports Third Quarter Fiscal 2016 Financial Results and Recent Corporate Highlights GlobeNewswire
07:07AM  Q3 2016 Corium International Inc Earnings Release - After Market Close
Jul-29-16 01:21PM  ETFs with exposure to Corium International, Inc. : July 29, 2016 +7.17%
Jul-28-16 08:00AM  Corium to Report Third Quarter Fiscal Year 2016 Financial Results on Thursday, August 4, 2016 GlobeNewswire
Jul-27-16 04:01PM  Corium Presents Full Clinical Results from Phase 1 Pharmacokinetic Study of Once-weekly Corplex Donepezil Transdermal System GlobeNewswire
09:57AM  Can The Uptrend Continue for Corium International (CORI)?
Jul-20-16 04:03PM  Corium to Present Clinical Data from a Phase 1 Pharmacokinetic Study of Once-Weekly Corplex Donepezil Transdermal System GlobeNewswire
Jul-05-16 04:21PM  Corium to Present at Cantor Fitzgeralds 2nd Annual Healthcare Conference GlobeNewswire
Jun-20-16 02:15PM  ETFs with exposure to Corium International, Inc. : June 20, 2016
Jun-15-16 05:05PM  CORIUM INTERNATIONAL, INC. Files SEC form 8-K, Costs Associated with Exit or Disposal Activities
Jun-07-16 11:08AM  Corium International, Inc. :CORI-US: Earnings Analysis: Q2, 2016 By the Numbers : June 7, 2016
May-25-16 04:05PM  Corium to Present at the Jefferies 2016 Healthcare Conference GlobeNewswire
May-13-16 04:08PM  CORIUM INTERNATIONAL, INC. Files SEC form 10-Q, Quarterly Report +5.26%
May-12-16 07:55AM  Edited Transcript of CORI earnings conference call or presentation 10-May-16 9:00pm GMT -7.18%
May-10-16 06:06PM  Corium reports 2Q loss
04:18PM  CORIUM INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an
04:03PM  Corium Reports Second Quarter Fiscal 2016 Financial Results and Recent Corporate Highlights GlobeNewswire
07:07AM  Q2 2016 Corium International Inc Earnings Release - After Market Close
May-04-16 08:15AM  Corium International (CORI) Jumps: Stock Moves 9.5% Higher
May-03-16 04:05PM  Corium to Report Second Quarter Fiscal Year 2016 Financial Results on Tuesday, May 10, 2016 GlobeNewswire +9.47%
08:41AM  Corium International upgraded by WBB Securities Briefing.com
May-02-16 04:05PM  Corium Announces Streamlined Bioequivalence Development Path for Transdermal Corplex Donepezil Following Positive Pre-IND Communication from FDA GlobeNewswire +6.03%
07:40AM  7 Stocks Under $10 Making Big Moves Toward Big Profits at TheStreet
Apr-14-16 03:00PM  ETFs with exposure to Corium International, Inc. : April 14, 2016
Apr-06-16 11:58AM  Corium International, Inc. :CORI-US: Earnings Analysis: Q1, 2016 By the Numbers +6.28%
Mar-31-16 08:00AM  Corium to Present at 15th Annual Needham Healthcare Conference GlobeNewswire
Corium International, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of specialty pharmaceutical products in transdermal and transmucosal delivery systems. It offers Clonidine Transdermal Delivery System (TDS), a treatment for hypertension; Fentanyl TDS, a treatment for the management of chronic pain, including cancer-related pain; and Crest Whitestrips for teeth whitening. The company's products under pipeline comprise Twirla, a combination hormonal contraceptive patch, which has completed Phase III clinical trial to deliver ethinyl estradiol and levonorgestrel hormones; MicroCor hPTH(1-34), a transdermal system that has completed Phase 1 and Phase II a clinical trial for the treatment of severe osteoporosis; and Donepezil and Memantine transdermal systems, which completed Phase I clinical trial for the treatment of Alzheimer's disease. In addition, it develops Aripiprazole TDS for the treatment for psychiatric disorders; Ropinirole TDS that is in preclinical stage for the treatment of Parkinson's disease; MicroCor Zolmitriptan that is in preclinical stage for treatment of migraine; and generic transdermal product for the prevention of nausea and vomiting associated with motion sickness. Corium International, Inc. has collaboration agreements primarily with The Procter & Gamble Company; Teva Pharmaceuticals USA, Inc.; Endo Pharmaceuticals, Inc.; Agile Therapeutics, Inc.; and Aequus Pharmaceuticals, Inc. The company was incorporated in 1995 and is headquartered in Menlo Park, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Broadfin Healthcare Master Fun10% OwnerOct 04Sale11.01218,1002,401,1074,218,626Oct 06 04:25 PM
STAPLE PETER DPresident & CEOAug 23Option Exercise2.1250,000106,050146,000Aug 23 07:27 PM
Singh ParminderCTO & Vice President, R&DAug 22Sale7.6122,822173,5617,940Aug 23 07:26 PM
GARDNER PHYLLISDirectorAug 21Option Exercise2.1233,06470,12934,203Aug 21 06:07 PM
Singh ParminderCTO & Vice President, R&DAug 21Sale7.537,59357,13930,762Aug 23 07:26 PM
Singh ParminderCTO & Vice President, R&DAug 17Option Exercise2.2058,415128,29870,355Aug 18 07:39 PM
Sweemer Timothy DChief Accounting OfficerAug 17Sale7.6212,01291,52932,355Aug 18 07:40 PM
Singh ParminderCTO & Vice President, R&DAug 17Sale7.6132,000243,61938,355Aug 18 07:39 PM
Sweemer Timothy DChief Accounting OfficerAug 16Option Exercise2.1954,949120,34759,855Aug 18 07:40 PM
Sweemer Timothy DChief Accounting OfficerAug 16Sale7.8215,488121,15644,367Aug 18 07:40 PM
Sarret Joseph J.Chief Business OfficerJul 20Sale8.952,03818,2327,462Jul 21 08:15 PM
PERCEPTIVE ADVISORS LLC10% OwnerJun 30Buy7.71301,0042,319,2365,847,133Jul 05 05:53 PM
PERCEPTIVE ADVISORS LLC10% OwnerMay 25Buy6.251,902,40011,890,0005,546,129May 25 10:29 AM
Sarret Joseph J.Chief Business OfficerFeb 16Option Exercise0.007,50008,500Feb 17 07:01 PM
STAPLE PETER DPresident & CEODec 28Option Exercise2.1250,000106,05095,000Dec 29 07:51 PM